Resverlogix Corp. (TSE:RVX – Get Free Report) crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of C$0.10 and traded as low as C$0.10. Resverlogix shares last traded at C$0.10, with a volume of 47,615 shares changing hands.
Resverlogix Price Performance
The firm has a market cap of C$30.11 million, a price-to-earnings ratio of -4.75 and a beta of 0.41. The company has a quick ratio of 0.04, a current ratio of 0.03 and a debt-to-equity ratio of -83.11. The company’s 50-day moving average price is C$0.10 and its 200-day moving average price is C$0.10.
Resverlogix (TSE:RVX – Get Free Report) last announced its quarterly earnings data on Friday, May 15th. The biotechnology company reported C$0.01 earnings per share for the quarter. On average, equities research analysts forecast that Resverlogix Corp. will post -0.22 EPS for the current year.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Read More
- Five stocks we like better than Resverlogix
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
